Bioactive factors for bone tissue engineering.

Orthopaedic surgery is currently in the midst of a transformation from bone grafting and the use of bone graft substitutes to bone tissue engineering. Bioactive bone growth factors likely will play a particularly important role in this emerging field. This article will review the three leading strategies for using bioactive factors for bone tissue engineering: extraction and partial purification of growth factors, recombinant protein synthesis, and gene therapy. Preclinical and early clinical trial results with bone morphogenetic protein-2, bone morphogenetic protein-7 (osteogenic protein-1), and NeOsteo bovine bone protein extract will be reviewed. In addition, the current obstacles to clinical implementation of bone tissue engineering will be reviewed.

[1]  M. Marone,et al.  Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.

[2]  L. Titus,et al.  1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.

[3]  N. Wright,et al.  Induction of Bone Formation Using a Recombinant Adenoviral Vector Carrying the Human BMP-2 Gene in a Rabbit Spinal Fusion Model , 1998, Calcified Tissue International.

[4]  L. Titus,et al.  Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2 , 1998 .

[5]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[6]  M. Mochizuki,et al.  Femoral nonunion fracture treated with recombinant human bone morphogenetic protein-2 in a dog. , 1998, The Journal of veterinary medical science.

[7]  S. Boden,et al.  Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage , 1998 .

[8]  T. Gerhart,et al.  Healing Bone Using Recombinant Human Bone Morphogenetic Protein 2 and Copolymer , 1998, Clinical orthopaedics and related research.

[9]  W. Larrabee,et al.  Mandibular Reconstruction With Transforming Growth Factor‐β1 , 1998 .

[10]  D. Silcox,et al.  Reversing the Inhibitory Effect of Nicotine on Spinal Fusion Using an Osteoinductive Protein Extract , 1998, Spine.

[11]  J. Helms,et al.  Expression of indian hedgehog, bone morphogenetic protein 6 and gli during skeletal morphogenesis 1 This work was presented in part at the 43rd Annual Meeting of the Orthopaedic Research Society, San Francisco, CA, February 1997. 1 , 1997, Mechanisms of Development.

[12]  J. Wozney,et al.  Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. , 1997, The International journal of oral & maxillofacial implants.

[13]  M. Bošković,et al.  Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. , 1997, The International journal of oral & maxillofacial implants.

[14]  J. Wozney,et al.  Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.

[15]  J. Dawson,et al.  Evaluation of bovine‐derived bone protein with a natural coral carrier as a bone‐graft substitute in a canine segmental defect model , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  S. Boonen,et al.  The prevention or treatment of age‐related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF‐I or rhTGFβ): a perspective , 1997, Journal of internal medicine.

[17]  C. Bosch,et al.  Recombinant Transforming Growth Factor‐β1 Induces Endochondral Bone in the Baboon and Synergizes with Recombinant Osteogenic Protein‐1 (Bone Morphogenetic Protein‐7) to Initiate Rapid Bone Formation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  R. Yacobi,et al.  A Collagenous Cementum‐Derived Attachment Protein Is a Marker for Progenitors of the Mineralized Tissue‐Forming Cell Lineage of the Periodontal Ligament , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  J. Dawson,et al.  Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model. , 1997, Journal of orthopaedic trauma.

[20]  J. Wozney,et al.  Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. , 1997, Endocrinology.

[21]  A. Linde,et al.  Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. , 1997, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[22]  J M Toth,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Without Decortication of Osseous Elements , 1997, Spine.

[23]  K Nakamura,et al.  Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  W. Hutton,et al.  In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. , 1997, Journal of spinal disorders.

[25]  P. Aspenberg,et al.  Basic Fibroblast Growth Factor Promotes Bone Ingrowth in Porous Hydroxyapatite , 1996, Clinical orthopaedics and related research.

[26]  S. Boden,et al.  Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.

[27]  M. Bostrom,et al.  Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats. , 1996, Bone.

[28]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[29]  J. Wozney,et al.  Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. , 1996, Endocrinology.

[30]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[31]  S. Goldstein,et al.  Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Hutton,et al.  Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials--rhBMP-2 and autograft. , 1996, Journal of spinal disorders.

[33]  P. Aspenberg,et al.  BMP-2 for intramuscular bone induction: effect in squirrel monkeys is dependent on implantation site. , 1996, Acta orthopaedica Scandinavica.

[34]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[35]  W C Hutton,et al.  The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part II Study of Dose, Carrier, and Species , 1995, Spine.

[36]  D. Silcox,et al.  The Effect of Nicotine on Spinal Fusion , 1995, Spine.

[37]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[38]  S. Cook,et al.  In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.

[39]  I. Asahina,et al.  Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria , 1993, The Journal of cell biology.

[40]  K. Ng,et al.  Differential effects of transforming growth factor‐β1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts , 1993, Journal of cellular physiology.

[41]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[42]  E. E. Johnson,et al.  Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.

[43]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[44]  V. Rosen,et al.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.

[45]  D. Weisman,et al.  Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. , 1990, Journal of biomedical materials research.

[46]  G. Stein,et al.  Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells , 1990, Journal of cellular physiology.

[47]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  V. Goldberg,et al.  Heterotopic osteogenesis in porous ceramics induced by marrow cells , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[50]  N Muthukumaran,et al.  Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[52]  D. Kingsley,et al.  What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.

[53]  P. Keto.  Percutaneous recanalization and stents of the biliary tree. , 1993, Annales chirurgiae et gynaecologiae.